Horn & Co. advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. completed the merger with Notable Labs and the sale of its IP assets....
Vascular Biogenics Ltd.’s Merger with Notable Labs
Vascular Biogenics Ltd.’s $28.3 Million Shares Offering
Goodwin Procter LLP advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT) announced the closing of its underwritten public offering...